April 2017 - Volume 27 - Issue 2 - Contributor Index

Alphabetical Search
I
Q
U
Y
Author:
Ali, Sayed
Author:
Allayous, Clara

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Author:
Amode, Reyhan

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy

Borroni, Riccardo G.; Manganoni, Ausilia M.; Grassi, Sara; More

Melanoma Research . 27(2):97-103, April 2017.

Author:
Bagot, Martine

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Author:
Bechter, Oliver

Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy

Borroni, Riccardo G.; Manganoni, Ausilia M.; Grassi, Sara; More

Melanoma Research . 27(2):97-103, April 2017.

Author:
Braun, Ralph
Author:
Cao, Xian
Author:
Carey, Kyle
Author:
Cassell, Oliver

Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy

Borroni, Riccardo G.; Manganoni, Ausilia M.; Grassi, Sara; More

Melanoma Research . 27(2):97-103, April 2017.

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues:...

Oba, Junna; Esmaeli, Bita; Ellerhorst, Julie A.; More

Melanoma Research . 27(2):126-133, April 2017.

Author:
Dai, Haiying
Author:
Dehler, Silvia
Author:
Dhawan, Ratika
Author:
Diegoli, Marta

Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy

Borroni, Riccardo G.; Manganoni, Ausilia M.; Grassi, Sara; More

Melanoma Research . 27(2):97-103, April 2017.

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues:...

Oba, Junna; Esmaeli, Bita; Ellerhorst, Julie A.; More

Melanoma Research . 27(2):126-133, April 2017.

Author:
Erturk, Kayhan
Author:
Esmaeli, Bita

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues:...

Oba, Junna; Esmaeli, Bita; Ellerhorst, Julie A.; More

Melanoma Research . 27(2):126-133, April 2017.

Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy

Borroni, Riccardo G.; Manganoni, Ausilia M.; Grassi, Sara; More

Melanoma Research . 27(2):97-103, April 2017.

Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy

Borroni, Riccardo G.; Manganoni, Ausilia M.; Grassi, Sara; More

Melanoma Research . 27(2):97-103, April 2017.

Author:
Grabbe, Stephan
Author:
Grassi, Sara

Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy

Borroni, Riccardo G.; Manganoni, Ausilia M.; Grassi, Sara; More

Melanoma Research . 27(2):97-103, April 2017.

Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy

Borroni, Riccardo G.; Manganoni, Ausilia M.; Grassi, Sara; More

Melanoma Research . 27(2):97-103, April 2017.

Author:
Gray, Arielle

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues:...

Oba, Junna; Esmaeli, Bita; Ellerhorst, Julie A.; More

Melanoma Research . 27(2):126-133, April 2017.

Author:
Gupta, Arjun
Author:
Jebali, Majdi

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Author:
Kaes, Joachim
Author:
Khine, Htet
Author:
Korol, Dimitri
Author:
Kowal, Anita

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Author:
Kuo, James
Author:
Ladwa, Rahul

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues:...

Oba, Junna; Esmaeli, Bita; Ellerhorst, Julie A.; More

Melanoma Research . 27(2):126-133, April 2017.

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Author:
Loquai, Carmen
Author:
Lv, Chuan

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues:...

Oba, Junna; Esmaeli, Bita; Ellerhorst, Julie A.; More

Melanoma Research . 27(2):126-133, April 2017.

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues:...

Oba, Junna; Esmaeli, Bita; Ellerhorst, Julie A.; More

Melanoma Research . 27(2):126-133, April 2017.

Author:
Madjlessi, Nika

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy

Borroni, Riccardo G.; Manganoni, Ausilia M.; Grassi, Sara; More

Melanoma Research . 27(2):97-103, April 2017.

Author:
Micevic, Goran

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues:...

Oba, Junna; Esmaeli, Bita; Ellerhorst, Julie A.; More

Melanoma Research . 27(2):126-133, April 2017.

Author:
Minini, Remo
Author:
Moncrieff, Marc
Author:
Münzel, Thomas
Author:
Oba, Junna

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues:...

Oba, Junna; Esmaeli, Bita; Ellerhorst, Julie A.; More

Melanoma Research . 27(2):126-133, April 2017.

Author:
Pagès, Cécile

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Author:
Pavoni, Laura

Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy

Borroni, Riccardo G.; Manganoni, Ausilia M.; Grassi, Sara; More

Melanoma Research . 27(2):97-103, April 2017.

Author:
Peach, Howard

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Author:
Rodic, Nemanja
Author:
Roux, Jennifer

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Author:
Shah, Udayan
Author:
Sun, Mengyan
Author:
Tas, Faruk
Author:
Taube, Janis M.
Author:
Terry, Nina L.

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients

Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; More

Melanoma Research . 27(2):110-115, April 2017.

Author:
Wang, Wei-Lien

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues:...

Oba, Junna; Esmaeli, Bita; Ellerhorst, Julie A.; More

Melanoma Research . 27(2):126-133, April 2017.

Author:
Wang, Yuchong
Author:
Wolter, Pascal
Author:
Wu, Kai
Author:
Xia, Zhaofan
Author:
Xue, Chunyu
Author:
Zhao, Hui
1 2 Next